Geneos Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Geneos Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Hold	1,722	–	–	﹤0.01%	983
2026 Q1	$179K	Buy	1,722 +335	+24%	+$35.4K	﹤0.01%	991
2025 Q4	$145K	Hold	1,387	–	–	﹤0.01%	1039
2025 Q3	$128K	Hold	1,387	–	–	﹤0.01%	1040
2025 Q2	$111K	Hold	1,387	–	–	﹤0.01%	1214
2025 Q1	$120K	Hold	1,387	–	–	﹤0.01%	1086
2024 Q4	$115K	Hold	1,387	–	–	﹤0.01%	1018
2024 Q3	$121K	Hold	1,387	–	–	﹤0.01%	907
2024 Q2	$114K	Sell	1,387 -663	-32%	-$52.7K	0.01%	835
2024 Q1	$164K	Buy	2,050 +980	+92%	+$75.9K	0.01%	744
2023 Q4	$81.4K	Hold	1,070	–	–	﹤0.01%	897
2023 Q3	$77.4K	Buy	1,070 +920	+613%	+$70.5K	﹤0.01%	948
2023 Q2	$11.3K	Hold	150	–	–	﹤0.01%	1543
2023 Q1	$11.4K	Hold	150	–	–	﹤0.01%	1514
2022 Q4	$11.8K	Hold	150	–	–	﹤0.01%	1487
2022 Q3	$10K	Sell	150 -50	-25%	-$3.73K	﹤0.01%	1518
2022 Q2	$15K	Hold	200	–	–	﹤0.01%	1816
2022 Q1	$15K	Hold	200	–	–	﹤0.01%	1920
2021 Q4	$16K	Hold	200	–	–	﹤0.01%	2000
2021 Q3	$15K	Hold	200	–	–	﹤0.01%	2068
2021 Q2	$16K	Hold	200	–	–	﹤0.01%	2025
2021 Q1	$15K	Hold	200	–	–	﹤0.01%	2211
2020 Q4	$15K	Hold	200	–	–	﹤0.01%	2057
2020 Q3	$12K	Hold	200	–	–	﹤0.01%	1885
2020 Q2	$12K	Hold	200	–	–	﹤0.01%	1842
2020 Q1	$10K	Hold	200	–	–	﹤0.01%	1823
2019 Q4	$12K	Hold	200	–	–	﹤0.01%	1898
2019 Q3	$11K	Hold	200	–	–	﹤0.01%	1866
2019 Q2	$12K	Sell	200 -20	-9%	-$1.23K	﹤0.01%	1846
2019 Q1	$14K	Hold	220	–	–	﹤0.01%	1719
2018 Q4	$13K	Sell	220 -483	-69%	-$32.6K	﹤0.01%	1699
2018 Q3	$51K	Buy	703 +465	+195%	+$33.4K	﹤0.01%	1169
2018 Q2	$15K	Buy	+238	New	+$15.3K	﹤0.01%	1569

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Geneos Wealth Management's PJP Position: Q2 2026 in Review

Geneos Wealth Management held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 1,722 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Geneos Wealth Management first reported a position in PJP in Q2 2018 and has held it in 33 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Geneos Wealth Management held 1,722 shares of Invesco Pharmaceuticals ETF worth $204K as of Q2 2026.
Geneos Wealth Management left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #983 holding.
Geneos Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2018 and has held it in 33 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.